Equity · Healthcare
ELAN
NYSEElanco Animal Health (ELAN)
The line runs 22.30 USD on 10 August through 25.73 USD on 6 November, on a scale from 20 to 26. Days the market did not trade hold the previous close, flat.
- Market cap
- 12.9B USD
- Revenue, year to Dec 2025
- 4.7B USD
- EPS, diluted, year to Dec 2025
- −0.47 USD
- 52-week range
- 19.81 USD – 26.83 USD
- Avg volume
- 549.1K
- Mentions, 30 days
- 1
as of Nov 6, 2026
Have Elanco Animal Health (ELAN) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Elanco Animal Health insiders reported 1 open-market sale and 3 purchases (SEC Form 4).
Form 4, 90 days to 9 Nov 2026, newest reported trade 15 Oct 2026
Buys 3Sells 1Net bought $1.04MOther filings 0
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Oct 2026 | Bettington Timothy JSEE REMARKS | Sell | 4,350 | 100K USD |
| 20 Aug 2026 | Kurzius Lawrence ErikDirector | Buy | 40,000 | 936K USD |
| 18 Aug 2026 | O'Neill ShivGC AND CORP SEC | Buy | 3,998 | 94K USD |
| 12 Aug 2026 | Harrington Michael JDirector | Buy | 5,000 | 109K USD |
| Bought | 3 open-market purchases | 48,998 | $1.14M | |
| Sold | 1 open-market sale | 4,350 | $100K |
Which funds hold Elanco Animal Health (ELAN)?
10 of the 45 institutional funds we track reported a Elanco Animal Health position for the quarter ended 30 Jun 2026 — a combined 435.2M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 9,668,611 | 237.9M USD | +120.4% |
| Marshall Wace | Added | 4,432,350 | 109.1M USD | +220.6% |
| Millennium Management | Added | 2,725,889 | 67.1M USD | +281.8% |
| Tudor Investment Corp | New position | 256,108 | 6.3M USD | |
| AQR Capital Management | Held (±25%) | 224,311 | 5.4M USD | +13.4% |
| Man Group | New position | 98,839 | 2.4M USD | |
| Maverick Capital | Trimmed | 98,098 | 2.4M USD | −32.1% |
| D. E. Shaw & Co. | Trimmed | 88,993 | 2.2M USD | −38.6% |
| Bridgewater Associates | Held (±25%) | 82,941 | 2.0M USD | −3.8% |
| Two Sigma Investments | New position | 12,622 | 311K USD |
Have members of Congress traded Elanco Animal Health (ELAN)?
The most recent congressional trade disclosed in Elanco Animal Health is a sale by Val T. Hoyle (house, OR), dated 23 Sep 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 23 Sep 2025 | Val T. Hoylehouse · Democrat–OR | Sale | 1K USD–15K USD | 17 days |
| 06 Mar 2023 | Daniel S. Goldmanhouse · Democrat–NY | Sale | 1K USD–15K USD | 42 days |
| 30 Nov 2022 | Susie Leehouse · Democrat–NV | Sale | 1K USD–15K USD | 29 days |
| 10 Jun 2021 | Susie Leehouse · Democrat–NV | Purchase | 1K USD–15K USD | 33 days |
| 06 Nov 2020 | Susie Leehouse · Democrat–NV | Sale | 1K USD–15K USD | 32 days |
What has been filed or recorded for Elanco Animal Health (ELAN)?
The filings we hold for Elanco Animal Health, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,845 shares | 64K USD notional · 0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 45 shares | 1K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 32 shares | 716 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.04 USD | Revenue $1.27B |
| 30 Sep 2026 | Financials | Total assets | 13.3B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 6.6B USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 3,913 shares | 88K USD notional · 0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.11 USD | Revenue $1.37B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.11 USD | Revenue $1.37B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.47 USD | Revenue $4.72B |
| 31 Dec 2025 | Financials | Revenue | 4.7B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −232.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.47 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.07 USD | Revenue $1.14B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.02 USD | Revenue $1.24B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.13 USD | Revenue $1.19B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.68 USD | Revenue $4.44B |
What is Reddit saying about Elanco Animal Health (ELAN)?
Reddit mentioned ELAN 1 times in the 30 days to 8 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 1Communities 1
How do Reddit mentions of Elanco Animal Health (ELAN) compare with its price?
Share ↗
Where Elanco Animal Health (ELAN) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.06 |
Elanco Animal Health (ELAN): frequently asked questions
What did Elanco Animal Health shares close at?
Elanco Animal Health closed at 25.73 USD on 6 Nov 2026, up 8.70% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Elanco Animal Health’s market cap?
Elanco Animal Health is worth 12.9B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Elanco Animal Health’s revenue?
Elanco Animal Health reported revenue of 4.7B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Elanco Animal Health insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Elanco Animal Health insiders reported 1 open-market sale and 3 purchases (SEC Form 4). See Insiders
Which funds own Elanco Animal Health?
10 of the 45 funds we track reported a Elanco Animal Health position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Marshall Wace and Millennium Management. See Funds
Have members of Congress traded Elanco Animal Health?
Yes. 5 trades in Elanco Animal Health appear in the congressional disclosures we hold; the latest is a sale by Val T. Hoyle (House, OR) dated 23 Sep 2025, filed 10 Oct 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Elanco Animal Health last report earnings?
Elanco Animal Health last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.04 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Elanco Animal Health?
Elanco Animal Health was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Elanco